SCHEMBL14824735

SCHEMBL14824735

CCn1c(=O)c(-c2ccc(C(=O)NN)cc2Cl)cc2cnc(Nc3ccc(N4CCN(C(C)C)CC4)cc3)nc21

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAK1 Q13153 6/20 0.66
PKN1 Q16512 4/20 0.66
PAK4 O96013 3/20 0.66
PAK2 Q13177 4/20 0.59
PAK3 O75914 3/20 0.59
WEE1 P30291 3/20 0.59
LIMK1 P53667 1/20 0.51
LIMK2 P53671 1/20 0.51
FGFR1 P11362 4/20 0.48
EGFR P00533 2/20 0.48
JAK3 P52333 2/20 0.48
CDK4 P11802 3/20 0.47
CCND1 P24385 3/20 0.47
CCND2 P30279 3/20 0.47
CCND3 P30281 3/20 0.47
SRC P12931 2/20 0.46
FGFR2 P21802 1/20 0.46
FGFR4 P22455 1/20 0.46
FGFR3 P22607 1/20 0.46
KCNH2 Q12809 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1680912 0.92 PAK1 (0.79) PAK1PKN1PAK4PAK2PAK3
SCHEMBL13554117 0.86 PAK1 (0.67) PAK1PKN1PAK4PAK2PAK3
SCHEMBL16310839 0.86 PAK1 (0.69) PAK1PKN1PAK4PAK2PAK3
SCHEMBL15035157 0.85 PAK1 (0.68) PAK1PKN1PAK4PAK2PAK3
SCHEMBL15035964 0.85 PAK1 (0.68) PAK1PKN1PAK4PAK2PAK3
SCHEMBL16309172 0.85 PAK1 (0.67) PAK1PKN1PAK4PAK2PAK3
SCHEMBL15035966 0.85 PAK1 (0.67) PAK1PKN1PAK4PAK2PAK3
SCHEMBL12807686 0.85 PAK1 (0.68) PAK1PKN1PAK4PAK2PAK3
SCHEMBL14682158 0.83 PAK1 (0.66) PAK1PKN1PAK4PAK2PAK3
SCHEMBL14824809 0.83 PAK1 (0.74) PAK1PKN1PAK4PAK2PAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013043232-A2 8-ETHYL-6-(ARYL)PYRIDO [2,3-D]PYRIMIDIN-7(8H) -ONES FOR THE TREATMENT OF NERVOUS SYSTEM DISORDERS AND CANCER AFRAXIS, INC. (US) 2013-03-28 WO disclosed